Syndax Pharmaceuticals (SNDX)
(Real Time Quote from BATS)
$23.30 USD
+0.02 (0.09%)
Updated Jul 24, 2024 10:18 AM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Price, Consensus and EPS Surprise
SNDX 23.30 +0.02(0.09%)
Will SNDX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SNDX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SNDX
Regeneron (REGN) to Report Q2 Earnings: What's in the Cards?
Wall Street Analysts Believe Syndax (SNDX) Could Rally 67.11%: Here's is How to Trade
SNDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA
Syndax (SNDX) is on the Move, Here's Why the Trend Could be Sustainable
Other News for SNDX
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax initiated with bullish view at Jefferies, here's why
Syndax price target raised by $2 at Stifel, here's why
Small-cap, buy-rated stocks with positive estimate revision factors - BofA
Syndax: Gearing Up For Launches